| |
| |
|
| Insider
Information: |
Ketchum Steven B |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
742,979 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$507,188 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
742,979 |
|
|
| Total
Value |
$507,188 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2015-07-24 |
84,259 |
2010-06-30 |
0 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
|
2024-01-31 |
658,720 |
2015-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-02-25 |
4 |
D |
$7.30 |
$330,887 |
D/D |
(45,327) |
426,283 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-02-26 |
4 |
D |
$6.74 |
$77,395 |
D/D |
(11,483) |
437,246 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-03-31 |
4 |
D |
$6.37 |
$19,925 |
D/D |
(3,128) |
440,230 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-04-30 |
4 |
D |
$5.24 |
$16,391 |
D/D |
(3,128) |
443,214 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-05-28 |
4 |
D |
$4.54 |
$14,201 |
D/D |
(3,128) |
446,198 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-06-30 |
4 |
D |
$4.48 |
$14,009 |
D/D |
(3,127) |
449,179 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-07-30 |
4 |
D |
$4.14 |
$12,946 |
D/D |
(3,127) |
452,160 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-08-31 |
4 |
D |
$5.54 |
$17,324 |
D/D |
(3,127) |
455,141 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2021-12-31 |
4 |
D |
$3.35 |
$81,851 |
D/D |
(24,433) |
478,475 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2022-01-31 |
4 |
D |
$3.36 |
$17,207 |
D/D |
(5,121) |
486,087 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2022-02-28 |
4 |
D |
$3.27 |
$18,011 |
D/D |
(5,508) |
496,912 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2022-07-29 |
4 |
D |
$1.33 |
$10,881 |
D/D |
(8,181) |
512,615 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2022-12-30 |
4 |
D |
$1.21 |
$19,797 |
D/D |
(16,361) |
544,021 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-01-31 |
4 |
D |
$1.86 |
$25,493 |
D/D |
(13,706) |
564,882 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-02-21 |
4 |
D |
$1.80 |
$26,136 |
D/D |
(14,520) |
579,496 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-02-28 |
4 |
D |
$2.03 |
$15,668 |
D/D |
(7,718) |
588,111 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2023-07-31 |
4 |
D |
$1.19 |
$13,998 |
D/D |
(11,763) |
600,231 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2024-01-04 |
4 |
D |
$0.87 |
$6,725 |
D/D |
(7,730) |
597,177 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2024-01-10 |
4 |
D |
$0.97 |
$27,422 |
D/D |
(28,270) |
620,407 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2024-01-31 |
4 |
D |
$1.24 |
$51,072 |
D/D |
(41,187) |
658,720 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-07 |
4 |
OE |
$2.09 |
$40,862 |
D/D |
19,551 |
93,512 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-08 |
4 |
OE |
$2.09 |
$21,951 |
D/D |
10,503 |
84,464 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President of R&D, SVP |
• – – |
2015-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
56,500 |
56,500 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2015-07-24 |
4 |
OE |
$1.32 |
$21,986 |
D/D |
16,656 |
86,378 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2016-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
117,438 |
173,938 |
0 |
- |
|
132 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
